Systems-wide proteomic characterization of combinatorial post-translational modification patterns

References

• Hirota T, Lipp JJ, Toh BH, Peters JM. Histone H3 serine 10 phosphorylation by Aurora B causes HP1 dissociation from heterochromatin. Nature438(7071), 1176–1180 (2005).
   PubMed Web of Science ®Google Scholar
• Fischle W, Tseng BS, Dormann HL et al. Regulation of HP1-chromatin binding by histone H3 methylation and phosphorylation. Nature438(7071), 1116–1122 (2005).
   PubMed Web of Science ®Google Scholar
• Fischle W, Wang Y, Allis CD. Binary switches and modification cassettes in histone biology and beyond. Nature425(6957), 475–479 (2003).
   PubMed Web of Science ®Google Scholar
• Garcia BA, Barber CM, Hake SB et al. Modifications of human histone H3 variants during mitosis. Biochemistry44(39), 13202–13213 (2005).
   PubMed Web of Science ®Google Scholar
• Jiang T, Zhou X, Taghizadeh K, Dong M, Dedon PC. N-formylation of lysine in histone proteins as a secondary modification arising from oxidative DNA damage. Proc. Natl Acad. Sci. USA104(1), 60–65 (2007).
   PubMed Web of Science ®Google Scholar
• Wisniewski JR, Zougman A, Kruger S, Mann M. Mass spectrometric mapping of linker histone H1 variants reveals multiple acetylations, methylations, and phosphorylation as well as differences between cell culture and tissue. Mol. Cell. Proteomics6(1), 72–87 (2007).
   PubMed Web of Science ®Google Scholar
• Ulrich HD. Mutual interactions between the SUMO and ubiquitin systems: a plea of no contest. Trends Cell Biol.15(10), 525–532 (2005).
   PubMedGoogle Scholar
• Heideker J, Perry JJ, Boddy MN. Genome stability roles of SUMO-targeted ubiquitin ligases. DNA Repair (Amst.)8(4), 517–524 (2009).
   PubMedGoogle Scholar
• Prudden J, Pebernard S, Raffa G et al. SUMO-targeted ubiquitin ligases in genome stability. EMBO J.26(18), 4089–4101 (2007).
   PubMed Web of Science ®Google Scholar
• Xie Y, Kerscher O, Kroetz MB, McConchie HF, Sung P, Hochstrasser M. The yeast Hex3.Slx8 heterodimer is a ubiquitin ligase stimulated by substrate sumoylation. J. Biol. Chem.282(47), 34176–34184 (2007).
   PubMed Web of Science ®Google Scholar
• Sun H, Leverson JD, Hunter T. Conserved function of RNF4 family proteins in eukaryotes: targeting a ubiquitin ligase to SUMOylated proteins. EMBO J.26(18), 4102–4112 (2007).
   PubMed Web of Science ®Google Scholar
• Tatham MH, Geoffroy MC, Shen L et al. RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation. Nat. Cell. Biol.10(5), 538–546 (2008).
   PubMed Web of Science ®Google Scholar
• Lallemand-Breitenbach V, Jeanne M, Benhenda S et al. Arsenic degrades PML or PML–RARα through a SUMO-triggered RNF4/ubiquitin-mediated pathway. Nat. Cell. Biol.10(5), 547–555 (2008).
   PubMed Web of Science ®Google Scholar
• Schimmel J, Larsen KM, Matic I et al. The ubiquitin-proteasome system is a key component of the SUMO-2/3 cycle. Mol. Cell. Proteomics7(11), 2107–2122 (2008).
   PubMedGoogle Scholar
• Sims JK, Houston SI, Magazinnik T, Rice JC. A trans-tail histone code defined by monomethylated H4 Lys-20 and H3 Lys-9 demarcates distinct regions of silent chromatin. J. Biol. Chem.281(18), 12760–12766 (2006).
   PubMed Web of Science ®Google Scholar
• Botuyan MV, Lee J, Ward IM et al. Structural basis for the methylation state-specific recognition of histone H4-K20 by 53BP1 and Crb2 in DNA repair. Cell127(7), 1361–1373 (2006).
   PubMed Web of Science ®Google Scholar
• Huyen Y, Zgheib O, Ditullio RA Jr et al. Methylated lysine 79 of histone H3 targets 53BP1 to DNA double-strand breaks. Nature432(7015), 406–411 (2004).
   PubMed Web of Science ®Google Scholar
• Strahl BD, Allis CD. The language of covalent histone modifications. Nature403(6765), 41–45 (2000).
   PubMed Web of Science ®Google Scholar
• Bonisch C, Nieratschker SM, Orfanos NK, Hake SB. Chromatin proteomics and epigenetic regulatory circuits. Exp. Rev. Proteomics5(1), 105–119 (2008).
   PubMed Web of Science ®Google Scholar
• Shi Y, Whetstine JR. Dynamic regulation of histone lysine methylation by demethylases. Mol. Cell25(1), 1–14 (2007).
   PubMed Web of Science ®Google Scholar
• Kouzarides T. Chromatin modifications and their function. Cell128(4), 693–705 (2007).
   PubMed Web of Science ®Google Scholar
• Garcia BA, Shabanowitz J, Hunt DF. Characterization of histones and their post-translational modifications by mass spectrometry. Curr. Opin. Chem. Biol.11(1), 66–73 (2007).
   PubMedGoogle Scholar
• Yang XJ. Multisite protein modification and intramolecular signaling. Oncogene24(10), 1653–1662 (2005).
   PubMed Web of Science ®Google Scholar
• Benayoun BA, Veitia RA. A post-translational modification code for transcription factors: sorting through a sea of signals. Trends Cell Biol.19(5), 189–197 (2009).
   PubMed Web of Science ®Google Scholar
• Joubel A, Chalkley RJ, Medzihradszky KF, Hondermarck H, Burlingame AL. Identification of new p53 acetylation sites in COS-1 cells. Mol. Cell. Proteomics8(6), 1167–1173 (2009).
   PubMedGoogle Scholar
• Kachirskaia I, Shi X, Yamaguchi H et al. Role for 53BP1 Tudor domain recognition of p53 dimethylated at lysine 382 in DNA damage signaling. J. Biol. Chem.283(50), 34660–34666 (2008).
   PubMedGoogle Scholar
• Li M, Luo J, Brooks CL, Gu W. Acetylation of p53 inhibits its ubiquitination by Mdm2. J. Biol. Chem.277(52), 50607–50611 (2002).
   PubMed Web of Science ®Google Scholar
• Milne DM, Palmer RH, Campbell DG, Meek DW. Phosphorylation of the p53 tumour-suppressor protein at three N-terminal sites by a novel casein kinase I-like enzyme. Oncogene7(7), 1361–1369 (1992).
   PubMed Web of Science ®Google Scholar
• Khanna KK, Keating KE, Kozlov S et al. ATM associates with and phosphorylates p53: mapping the region of interaction. Nat. Genet.20(4), 398–400 (1998).
   PubMed Web of Science ®Google Scholar
• Dumaz N, Milne DM, Meek DW. Protein kinase CK1 is a p53-threonine 18 kinase which requires prior phosphorylation of serine 15. FEBS Lett.463(3), 312–316 (1999).
   PubMed Web of Science ®Google Scholar
• Lopez-Borges S, Lazo PA. The human vaccinia-related kinase 1 (VRK1) phosphorylates threonine-18 within the Mdm-2 binding site of the p53 tumour suppressor protein. Oncogene19(32), 3656–3664 (2000).
   PubMed Web of Science ®Google Scholar
• Okorokov AL, Ponchel F, Milner J. Induced N- and C-terminal cleavage of p53: a core fragment of p53, generated by interaction with damaged DNA, promotes cleavage of the N-terminus of full-length p53, whereas ssDNA induces C-terminal cleavage of p53. EMBO J.16(19), 6008–6017 (1997).
   PubMed Web of Science ®Google Scholar
• Chehab NH, Malikzay A, Stavridi ES, Halazonetis TD. Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage. Proc. Natl Acad. Sci. USA96(24), 13777–13782 (1999).
   PubMed Web of Science ®Google Scholar
• Turenne GA, Price BD. Glycogen synthase kinase3 β phosphorylates serine 33 of p53 and activates p53’s transcriptional activity. BMC Cell. Biol.2, 12 (2001).
   PubMedGoogle Scholar
• Radhakrishnan SK, Gartel AL. CDK9 phosphorylates p53 on serine residues 33, 315 and 392. Cell Cycle5(5), 519–521 (2006).
   PubMed Web of Science ®Google Scholar
• Zheng H, You H, Zhou XZ et al. The prolyl isomerase Pin1 is a regulator of p53 in genotoxic response. Nature419(6909), 849–853 (2002).
   PubMed Web of Science ®Google Scholar
• Sakaguchi K, Herrera JE, Saito S et al. DNA damage activates p53 through a phosphorylation–acetylation cascade. Genes Dev.12(18), 2831–2841 (1998).
   PubMed Web of Science ®Google Scholar
• Wulf GM, Liou YC, Ryo A, Lee SW, Lu KP. Role of Pin1 in the regulation of p53 stability and p21 transactivation, and cell cycle checkpoints in response to DNA damage. J. Biol. Chem.277(50), 47976–47979 (2002).
   PubMed Web of Science ®Google Scholar
• Zacchi P, Gostissa M, Uchida T et al. The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults. Nature419(6909), 853–857 (2002).
   PubMed Web of Science ®Google Scholar
• D’Orazi G, Cecchinelli B, Bruno T et al. Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis. Nat. Cell Biol.4(1), 11–19 (2002).
   PubMed Web of Science ®Google Scholar
• Yeh PY, Chuang SE, Yeh KH, Song YC, Cheng AL. Nuclear extracellular signal-regulated kinase 2 phosphorylates p53 at Thr55 in response to doxorubicin. Biochem. Biophys. Res. Commun.284(4), 880–886 (2001).
   PubMedGoogle Scholar
• Buschmann T, Potapova O, Bar-Shira A et al. Jun NH2-terminal kinase phosphorylation of p53 on Thr-81 is important for p53 stabilization and transcriptional activities in response to stress. Mol. Cell. Biol.21(8), 2743–2754 (2001).
   PubMed Web of Science ®Google Scholar
• Berger M, Stahl N, Del Sal G, Haupt Y. Mutations in proline 82 of p53 impair its activation by Pin1 and Chk2 in response to DNA damage. Mol. Cell. Biol.25(13), 5380–5388 (2005).
   PubMedGoogle Scholar
• Matsuoka S, Ballif BA, Smogorzewska A et al. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science316(5828), 1160–1166 (2007).
   PubMed Web of Science ®Google Scholar
• Tang Y, Luo J, Zhang W, Gu W. Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis. Mol. Cell24(6), 827–839 (2006).
   PubMed Web of Science ®Google Scholar
• Sykes SM, Mellert HS, Holbert MA et al. Acetylation of the p53 DNA-binding domain regulates apoptosis induction. Mol. Cell24(6), 841–851 (2006).
   PubMed Web of Science ®Google Scholar
• Yang WH, Kim JE, Nam HW et al. Modification of p53 with O-linked N-acetylglucosamine regulates p53 activity and stability. Nat. Cell. Biol.8(10), 1074–1083 (2006).
   PubMed Web of Science ®Google Scholar
• Uhle S, Medalia O, Waldron R et al. Protein kinase CK2 and protein kinase D are associated with the COP9 signalosome. EMBO J.22(6), 1302–1312 (2003).
   PubMed Web of Science ®Google Scholar
• Bech-Otschir D, Kraft R, Huang X et al. COP9 signalosome-specific phosphorylation targets p53 to degradation by the ubiquitin system. EMBO J.20(7), 1630–1639 (2001).
   PubMed Web of Science ®Google Scholar
• Tang Y, Zhao W, Chen Y, Zhao Y, Gu W. Acetylation is indispensable for p53 activation. Cell133(4), 612–626 (2008).
   PubMed Web of Science ®Google Scholar
• Wang YH, Tsay YG, Tan BC, Lo WY, Lee SC. Identification and characterization of a novel p300-mediated p53 acetylation site, lysine 305. J. Biol. Chem.278(28), 25568–25576 (2003).
   PubMedGoogle Scholar
• Price BD, Hughes-Davies L, Park SJ. Cdk2 kinase phosphorylates serine 315 of human p53 in vitro. Oncogene11(1), 73–80 (1995).
   PubMed Web of Science ®Google Scholar
• Le Cam L, Linares LK, Paul C et al. E4F1 is an atypical ubiquitin ligase that modulates p53 effector functions independently of degradation. Cell127(4), 775–788 (2006).
   PubMed Web of Science ®Google Scholar
• Abida WM, Nikolaev A, Zhao W, Zhang W, Gu W. FBXO11 promotes the Neddylation of p53 and inhibits its transcriptional activity. J. Biol. Chem.282(3), 1797–1804 (2007).
   PubMed Web of Science ®Google Scholar
• Kruse JP, Gu W. MSL2 promotes Mdm2-independent cytoplasmic localization of p53. J. Biol. Chem.284(5), 3250–3263 (2009).
   PubMed Web of Science ®Google Scholar
• Ou YH, Chung PH, Sun TP, Shieh SY. p53 C-terminal phosphorylation by CHK1 and CHK2 participates in the regulation of DNA-damage-induced C-terminal acetylation. Mol. Biol. Cell.16(4), 1684–1695 (2005).
   PubMedGoogle Scholar
• Gu W, Roeder RG. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell90(4), 595–606 (1997).
   PubMed Web of Science ®Google Scholar
• Huang J, Perez-Burgos L, Placek BJ et al. Repression of p53 activity by Smyd2-mediated methylation. Nature444(7119), 629–632 (2006).
   PubMed Web of Science ®Google Scholar
• Huang J, Sengupta R, Espejo AB et al. p53 is regulated by the lysine demethylase LSD1. Nature449(7158), 105–108 (2007).
   PubMed Web of Science ®Google Scholar
• Rodriguez MS, Desterro JM, Lain S, Lane DP, Hay RT. Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation. Mol. Cell. Biol.20(22), 8458–8467 (2000).
   PubMed Web of Science ®Google Scholar
• Xirodimas DP, Saville MK, Bourdon JC, Hay RT, Lane DP. Mdm2-mediated NEDD8 conjugation of p53 inhibits its transcriptional activity. Cell118(1), 83–97 (2004).
   PubMed Web of Science ®Google Scholar
• Youmell M, Park SJ, Basu S, Price BD. Regulation of the p53 protein by protein kinase C α and protein kinase C ζ. Biochem. Biophys. Res. Commun.245(2), 514–518 (1998).
   PubMedGoogle Scholar
• Chuikov S, Kurash JK, Wilson JR et al. Regulation of p53 activity through lysine methylation. Nature432(7015), 353–360 (2004).
   PubMed Web of Science ®Google Scholar
• Waterman MJ, Stavridi ES, Waterman JL, Halazonetis TD. ATM-dependent activation of p53 involves dephosphorylation and association with 14-13-3 proteins. Nat. Genet.19(2), 175–178 (1998).
   PubMed Web of Science ®Google Scholar
• Shi X, Kachirskaia I, Yamaguchi H et al. Modulation of p53 function by SET8-mediated methylation at lysine 382. Mol. Cell27(4), 636–646 (2007).
   PubMed Web of Science ®Google Scholar
• Gostissa M, Hengstermann A, Fogal V et al. Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1. EMBO J.18(22), 6462–6471 (1999).
   PubMed Web of Science ®Google Scholar
• Stewart ZA, Tang LJ, Pietenpol JA. Increased p53 phosphorylation after microtubule disruption is mediated in a microtubule inhibitor- and cell-specific manner. Oncogene20(1), 113–124 (2001).
   PubMed Web of Science ®Google Scholar
• Knights CD, Catania J, Di Giovanni S et al. Distinct p53 acetylation cassettes differentially influence gene-expression patterns and cell fate. J. Cell. Biol.173(4), 533–544 (2006).
   PubMed Web of Science ®Google Scholar
• Li AG, Piluso LG, Cai X, Gadd BJ, Ladurner AG, Liu X. An acetylation switch in p53 mediates holo-TFIID recruitment. Mol. Cell28(3), 408–421 (2007).
   PubMedGoogle Scholar
• Ivanov GS, Ivanova T, Kurash J et al. Methylation-acetylation interplay activates p53 in response to DNA damage. Mol. Cell. Biol.27(19), 6756–6769 (2007).
   PubMed Web of Science ®Google Scholar
• Meek DW. Multisite phosphorylation and the integration of stress signals at p53. Cell Signal.10(3), 159–166 (1998).
   PubMed Web of Science ®Google Scholar
• Xiao T, Hall H, Kizer KO et al. Phosphorylation of RNA polymerase II CTD regulates H3 methylation in yeast. Genes Dev.17(5), 654–663 (2003).
   PubMed Web of Science ®Google Scholar
• Corden JL. Tails of RNA polymerase II. Trends Biochem. Sci.15(10), 383–387 (1990).
   PubMed Web of Science ®Google Scholar
• Akhtar MS, Heidemann M, Tietjen JR et al. TFIIH kinase places bivalent marks on the carboxy-terminal domain of RNA polymerase II. Mol. Cell34(3), 387–393 (2009).
   PubMed Web of Science ®Google Scholar
• Kelly WG, Dahmus ME, Hart GW. RNA polymerase II is a glycoprotein. Modification of the COOH-terminal domain by O-GlcNAc. J. Biol. Chem.268(14), 10416–10424 (1993).
   PubMed Web of Science ®Google Scholar
• Xu YX, Manley JL. Pinning down transcription: regulation of RNA polymerase II activity during the cell cycle. Cell Cycle3(4), 432–435 (2004).
   PubMedGoogle Scholar
• Friebe S, Hartrodt B, Neubert K, Krauss GJ. High-performance liquid chromatographic separation of cis–trans isomers of proline-containing peptides. II. Fractionation in different cyclodextrin systems. J. Chromatogr. A661(1–2), 7–12 (1994).
   PubMedGoogle Scholar
• Counterman AE, Clemmer DE. Cis–trans signatures of proline-containing tryptic peptides in the gas phase. Anal. Chem.74(9), 1946–1951 (2002).
   PubMedGoogle Scholar
• Grigorean G, Cong X, Lebrilla CB. Chiral analyses of peptides by ion/molecule reactions. Int. J. Mass Spectrom.234(1–3), 71–77 (2004).
   Web of Science ®Google Scholar
• Ewing MA, Wang J, Sheeley SA, Sweedler JV. Detecting D-amino acid-containing neuropeptides using selective enzymatic digestion. Anal. Chem.80(8), 2874–2880 (2008).
   PubMed Web of Science ®Google Scholar
• Edde B, Rossier J, Le Caer JP, Desbruyeres E, Gros F, Denoulet P. Posttranslational glutamylation of α-tubulin. Science247(4938), 83–85 (1990).
   PubMed Web of Science ®Google Scholar
• Audebert S, Desbruyeres E, Gruszczynski C et al. Reversible polyglutamylation of α- and β-tubulin and microtubule dynamics in mouse brain neurons. Mol. Biol. Cell4(6), 615–626 (1993).
   PubMedGoogle Scholar
• van Dijk J, Rogowski K, Miro J, Lacroix B, Edde B, Janke C. A targeted multienzyme mechanism for selective microtubule polyglutamylation. Mol. Cell26(3), 437–448 (2007).
   PubMedGoogle Scholar
• Janke C, Rogowski K, Wloga D et al. Tubulin polyglutamylase enzymes are members of the TTL domain protein family. Science308(5729), 1758–1762 (2005).
   PubMedGoogle Scholar
• Redeker V, Levilliers N, Schmitter JM et al. Polyglycylation of tubulin: a posttranslational modification in axonemal microtubules. Science266(5191), 1688–1691 (1994).
   PubMedGoogle Scholar
• Ersfeld K, Wehland J, Plessmann U, Dodemont H, Gerke V, Weber K. Characterization of the tubulin-tyrosine ligase. J. Cell. Biol.120(3), 725–732 (1993).
   PubMedGoogle Scholar
• Hallak ME, Rodriguez JA, Barra HS, Caputto R. Release of tyrosine from tyrosinated tubulin. Some common factors that affect this process and the assembly of tubulin. FEBS Lett.73(2), 147–150 (1977).
   PubMedGoogle Scholar
• Paturle L, Wehland J, Margolis RL, Job D. Complete separation of tyrosinated, detyrosinated, and nontyrosinatable brain tubulin subpopulations using affinity chromatography. Biochemistry28(6), 2698–2704 (1989).
   PubMedGoogle Scholar
• Paturle-Lafanechere L, Manier M, Trigault N, Pirollet F, Mazarguil H, Job D. Accumulation of δ2-tubulin, a major tubulin variant that cannot be tyrosinated, in neuronal tissues and in stable microtubule assemblies. J. Cell. Sci.107(Pt 6), 1529–1543 (1994).
   PubMed Web of Science ®Google Scholar
• Paturle-Lafanechere L, Edde B, Denoulet P et al. Characterization of a major brain tubulin variant which cannot be tyrosinated. Biochemistry30(43), 10523–10528 (1991).
   PubMedGoogle Scholar
• L’Hernault SW, Rosenbaum JL. Chlamydomonas α-tubulin is posttranslationally modified by acetylation on the ε-amino group of a lysine. Biochemistry24(2), 473–478 (1985).
   PubMed Web of Science ®Google Scholar
• Eipper BA. Properties of rat brain tubulin. J. Biol. Chem.249(5), 1407–1416 (1974).
   PubMedGoogle Scholar
• Eipper BA. Rat brain tubulin and protein kinase activity. J. Biol. Chem.249(5), 1398–1406 (1974).
   PubMed Web of Science ®Google Scholar
• Gard DL, Kirschner MW. A polymer-dependent increase in phosphorylation of β-tubulin accompanies differentiation of a mouse neuroblastoma cell line. J. Cell. Biol.100(3), 764–774 (1985).
   PubMed Web of Science ®Google Scholar
• Caron JM. Posttranslational modification of tubulin by palmitoylation: I. In vivoand cell-free studies. Mol. Biol. Cell8(4), 621–636 (1997).
   PubMedGoogle Scholar
• Ozols J, Caron JM. Posttranslational modification of tubulin by palmitoylation: II. Identification of sites of palmitoylation. Mol. Biol. Cell8(4), 637–645 (1997).
   PubMedGoogle Scholar
• Reed NA, Cai D, Blasius TL et al. Microtubule acetylation promotes kinesin-1 binding and transport. Curr. Biol.16(21), 2166–2172 (2006).
   PubMed Web of Science ®Google Scholar
• Lin SX, Gundersen GG, Maxfield FR. Export from pericentriolar endocytic recycling compartment to cell surface depends on stable, detyrosinated (glu) microtubules and kinesin. Mol. Biol. Cell13(1), 96–109 (2002).
   PubMed Web of Science ®Google Scholar
• Peris L, Thery M, Faure J et al. Tubulin tyrosination is a major factor affecting the recruitment of CAP-Gly proteins at microtubule plus ends. J. Cell Biol.174(6), 839–849 (2006).
   PubMed Web of Science ®Google Scholar
• Redeker V, Levilliers N, Vinolo E et al. Mutations of tubulin glycylation sites reveal cross-talk between the C termini of α- and β-tubulin and affect the ciliary matrix in Tetrahymena. J. Biol. Chem.280(1), 596–606 (2005).
   PubMedGoogle Scholar
• Hammond JW, Cai D, Verhey KJ. Tubulin modifications and their cellular functions. Curr. Opin. Cell Biol.20(1), 71–76 (2008).
   PubMed Web of Science ®Google Scholar
• Verhey KJ, Gaertig J. The tubulin code. Cell Cycle,6(17), 2152–2160 (2007).
   PubMed Web of Science ®Google Scholar
• Westermann S, Weber K. Post-translational modifications regulate microtubule function. Nat. Rev. Mol. Cell Biol.4(12), 938–947 (2003).
   PubMed Web of Science ®Google Scholar
• Grosschedl R, Giese K, Pagel J. HMG domain proteins: architectural elements in the assembly of nucleoprotein structures. Trends Genet.10(3), 94–100 (1994).
   PubMed Web of Science ®Google Scholar
• Chiappetta G, Bandiera A, Berlingieri MT et al. The expression of the high mobility group HMGI (Y) proteins correlates with the malignant phenotype of human thyroid neoplasias. Oncogene10(7), 1307–1314 (1995).
   PubMed Web of Science ®Google Scholar
• Giancotti V, Berlingieri MT, DiFiore PP, Fusco A, Vecchio G, Crane-Robinson C. Changes in nuclear proteins on transformation of rat epithelial thyroid cells by a murine sarcoma retrovirus. Cancer Res.45(12 Pt 1), 6051–6057 (1985).
   PubMed Web of Science ®Google Scholar
• Giancotti V, Buratti E, Perissin L et al. Analysis of the HMGI nuclear proteins in mouse neoplastic cells induced by different procedures. Exp. Cell Res.184(2), 538–545 (1989).
   PubMedGoogle Scholar
• Chiappetta G, Avantaggiato V, Visconti R et al. High level expression of the HMGI (Y) gene during embryonic development. Oncogene13(11), 2439–2446 (1996).
   PubMed Web of Science ®Google Scholar
• Zhou X, Benson KF, Ashar HR, Chada K. Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C. Nature376(6543), 771–774 (1995).
   PubMed Web of Science ®Google Scholar
• Reeves R, Wolffe AP. Substrate structure influences binding of the non-histone protein HMG-I (Y) to free nucleosomal DNA. Biochemistry35(15), 5063–5074 (1996).
   PubMed Web of Science ®Google Scholar
• Reeves R, Nissen MS. Interaction of high mobility group-I (Y) nonhistone proteins with nucleosome core particles. J. Biol. Chem.268(28), 21137–21146 (1993).
   PubMedGoogle Scholar
• Reeves R, Leonard WJ, Nissen MS. Binding of HMG-I (Y) imparts architectural specificity to a positioned nucleosome on the promoter of the human interleukin-2 receptor a gene. Mol. Cell Biol.20(13), 4666–4679 (2000).
   PubMed Web of Science ®Google Scholar
• Zhang Q, Wang Y. High mobility group proteins and their post-translational modifications. Biochim. Biophys. Acta1784(9), 1159–1166 (2008).
   PubMed Web of Science ®Google Scholar
• Elton TS, Reeves R. Purification and postsynthetic modifications of Friend erythroleukemic cell high mobility group protein HMG-I. Anal. Biochem.157(1), 53–62 (1986).
   PubMedGoogle Scholar
• Lund T, Holtlund J, Laland SG. On the phosphorylation of low molecular mass HMG (high mobility group) proteins in Ehrlich ascites cells. FEBS Lett.180(2), 275–279 (1985).
   PubMedGoogle Scholar
• Zhang Q, Wang Y. High mobility group proteins and their post-translational modifications. Biochim. Biophys. Acta1784(9), 1159–1166 (2008).
   PubMed Web of Science ®Google Scholar
• Nissen MS, Langan TA, Reeves R. Phosphorylation by cdc2 kinase modulates DNA binding activity of high mobility group I nonhistone chromatin protein. J. Biol. Chem.266(30), 19945–19952 (1991).
   PubMed Web of Science ®Google Scholar
• Harrer M, Luhrs H, Bustin M, Scheer U, Hock R. Dynamic interaction of HMGA1a proteins with chromatin. J. Cell. Sci.117(Pt 16), 3459–3471 (2004).
   PubMedGoogle Scholar
• Banks GC, Li Y, Reeves R. Differential In vivo modifications of the HMGI(Y) nonhistone chromatin proteins modulate nucleosome and DNA interactions. Biochemistry39(28), 8333–8346 (2000).
   PubMedGoogle Scholar
• Edberg DD, Bruce JE, Siems WF, Reeves R. In vivo posttranslational modifications of the high mobility group A1a proteins in breast cancer cells of differing metastatic potential. Biochemistry43(36), 11500–11515 (2004).
   PubMedGoogle Scholar
• Bergel M, Herrera JE, Thatcher BJ et al. Acetylation of novel sites in the nucleosomal binding domain of chromosomal protein HMG-14 by p300 alters its interaction with nucleosomes. J. Biol. Chem.275(15), 11514–11520 (2000).
   PubMed Web of Science ®Google Scholar
• Herrera JE, Sakaguchi K, Bergel M, Trieschmann L, Nakatani Y, Bustin M. Specific acetylation of chromosomal protein HMG-17 by PCAF alters its interaction with nucleosomes. Mol. Cell. Biol.19(5), 3466–3473 (1999).
   PubMed Web of Science ®Google Scholar
• Zubarev RA, Kelleher NL, McLafferty FW. Electron capture dissociation of multiply charged protein cations. a nonergodic process. J. Am. Chem. Soc.120(13), 3265–3266 (1998).
   Web of Science ®Google Scholar
• Syka JE, Coon JJ, Schroeder MJ, Shabanowitz J, Hunt DF. Peptide and protein sequence analysis by electron transfer dissociation mass spectrometry. Proc. Natl Acad. Sci. USA101(26), 9528–9533 (2004).
   PubMed Web of Science ®Google Scholar
• Zubarev RA, Zubarev AR, Savitski MM. Electron capture/transfer versus collisionally activated/induced dissociations: solo or duet? J. Am. Soc. Mass Spectrom.19(6), 753–761 (2008).
   PubMedGoogle Scholar
• Macek B, Waanders LF, Olsen JV, Mann M. Top–down protein sequencing and MS3 on a hybrid linear quadrupole ion trap-orbitrap mass spectrometer. Mol. Cell. Proteomics5(5), 949–958 (2006).
   PubMed Web of Science ®Google Scholar
• Wysocki VH, Tsaprailis G, Smith LL, Breci LA. Mobile and localized protons: a framework for understanding peptide dissociation. J. Mass Spectrom.35(12), 1399–1406 (2000).
   PubMed Web of Science ®Google Scholar
• Siuti N, Kelleher NL. Decoding protein modifications using top–down mass spectrometry. Nat. Methods4(10), 817–821 (2007).
   PubMed Web of Science ®Google Scholar
• Lindner HH. Analysis of histones, histone variants, and their post-translationally modified forms. Electrophoresis29(12), 2516–2532 (2008).
   PubMedGoogle Scholar
• Bonenfant D, Coulot M, Towbin H, Schindler P, van Oostrum J. Characterization of histone H2A and H2B variants and their post-translational modifications by mass spectrometry. Mol. Cell Proteomics6(11), 1917–1932 (2006).
   Google Scholar
• Hake SB, Garcia BA, Duncan EM et al. Expression patterns and post-translational modifications associated with mammalian histone H3 variants. J. Biol. Chem.281(1), 559–568 (2006).
   PubMedGoogle Scholar
• Hake SB, Garcia BA, Kauer M et al. Serine 31 phosphorylation of histone variant H3.3 is specific to regions bordering centromeres in metaphase chromosomes. Proc. Natl Acad. Sci. USA102(18), 6344–6349 (2005).
   PubMed Web of Science ®Google Scholar
• Garcia BA, Pesavento JJ, Mizzen CA, Kelleher NL. Pervasive combinatorial modification of histone H3 in human cells. Nat. Methods4(6), 487–489 (2007).
   PubMed Web of Science ®Google Scholar
• Phanstiel D, Brumbaugh J, Berggren WT et al. Mass spectrometry identifies and quantifies 74 unique histone H4 isoforms in differentiating human embryonic stem cells. Proc. Natl Acad. Sci. USA105(11), 4093–4098 (2008).
   PubMedGoogle Scholar
• Young NL, Dimaggio PA, Plazas-Mayorca MD, Baliban RC, Floudas CA, Garcia BA. High-throughput characterization of combinatorial histone codes. Mol. Cell. Proteomics8(10), 2266–2284 (2009).
   PubMed Web of Science ®Google Scholar
• Pesavento JJ, Bullock CR, LeDuc RD, Mizzen CA, Kelleher NL. Combinatorial modification of human histone H4 quantitated by two-dimensional liquid chromatography coupled with top down mass spectrometry. J. Biol. Chem.283(22), 14927–14937 (2008).
   PubMed Web of Science ®Google Scholar
• Jiang L, Smith JN, Anderson SL, Ma P, Mizzen CA, Kelleher NL. Global assessment of combinatorial post-translational modification of core histones in yeast using contemporary mass spectrometry. LYS4 trimethylation correlates with degree of acetylation on the same H3 tail. J. Biol. Chem.282(38), 27923–27934 (2007).
   PubMedGoogle Scholar
• Medzihradszky KF, Zhang X, Chalkley RJ et al. Characterization of Tetrahymena histone H2B variants and posttranslational populations by electron capture dissociation (ECD) Fourier transform ion cyclotron mass spectrometry (FT-ICR MS). Mol. Cell Proteomics3(9), 872–886 (2004).
   PubMedGoogle Scholar
• Siuti N, Roth MJ, Mizzen CA, Kelleher NL, Pesavento JJ. Gene-specific characterization of human histone H2B by electron capture dissociation. J. Proteome Res.5(2), 233–239 (2006).
   PubMed Web of Science ®Google Scholar
• Boyne MT 2nd, Pesavento JJ, Mizzen CA, Kelleher NL. Precise characterization of human histones in the H2A gene family by top down mass spectrometry. J. Proteome Res.5(2), 248–253 (2006).
   PubMed Web of Science ®Google Scholar
• Thomas CE, Kelleher NL, Mizzen CA. Mass spectrometric characterization of human histone H3: a bird’s eye view. J. Proteome Res.5(2), 240–247 (2006).
   PubMed Web of Science ®Google Scholar
• Taverna SD, Ueberheide BM, Liu Y et al. Long-distance combinatorial linkage between methylation and acetylation on histone H3 N termini. Proc. Natl Acad. Sci. USA104(7), 2086–2091 (2007).
   PubMed Web of Science ®Google Scholar
• Mayya V, Rezual K, Wu L, Fong MB, Han DK. Absolute quantification of multisite phosphorylation by selective reaction monitoring mass spectrometry: determination of inhibitory phosphorylation status of cyclin-dependent kinases. Mol. Cell. Proteomics5(6), 1146–1157 (2006).
   PubMed Web of Science ®Google Scholar
• Soufi B, Gnad F, Jensen PR et al. The Ser/Thr/Tyr phosphoproteome of Lactococcus lactis IL1403 reveals multiply phosphorylated proteins. Proteomics8(17), 3486–3493 (2008).
   PubMedGoogle Scholar
• Wisniewski JR, Zougman A, Kruger S et al. Constitutive and dynamic phosphorylation and acetylation sites on NUCKS, a hypermodified nuclear protein, studied by quantitative proteomics. Proteins73(3), 710–718 (2008).
   PubMedGoogle Scholar